
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Ear cartilage is more prone to a nasty infection than the earlobe during jewelry piercing. The infection can cause disfiguring